N-stearoyltyrosine protects primary neurons from Aβ-induced apoptosis through modulating mitogen-activated protein kinase activity

Neuroscience

Volumn 169, Issue 4, 2010, Pages 1840-1847

  Yang, Z H ^a   Sun, K ^b   Suo, W H ^a   Yao, L Y ^a   Fu, Q ^a   Cui, Y Y ^a   Fu, G H ^a   Chen, H Z ^a   Lu, Y ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

Anandamide; Apoptosis; A ; MAPK; N stearoyltyrosine

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; AMYLOID BETA PROTEIN[25-35]; ANANDAMIDE; HOE 33342; LACTATE DEHYDROGENASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; N STEAROYLTYROSINE; PROTEIN BAX; PROTEIN BCL 2; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; BRAIN NERVE CELL; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME PHOSPHORYLATION; FLOW CYTOMETRY; NERVE CELL CULTURE; NERVE CELL LESION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; RAT; STAINING; WESTERN BLOTTING;

EID: 77955427099     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2010.05.069     Document Type: Article

References (36)

1. Beeler N., Riederer B.M., Waeber G., Abderrahmani A. Role of the JNK-interacting protein. 1/islet brain 1 in cell degeneration in Alzheimer disease and diabetes. Brain Res Bull 2009, 80:274-281.
2. Benito C., Nunez E., Tolon R.M., Carrier E.J., Rabano A., Hillard C.J., Romero J. Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains. J Neurosci 2003, 23:11136-11141.
3. Burstein S. The elmiric acids: biologically active anandamide analogs. Neuropharmacology 2008, 55:1259-1264.
4. Chang L., Karin M. Mammalian MAP kinase signalling cascades. Nature 2001, 410:37-40.
5. Chong Y.H., Shin Y.J., Lee E.O., Kayed R., Glabe C.G., Tenner A.J. ERK1/2 activation mediates Abeta oligomer-induced neurotoxicity via caspase-3 activation and tau cleavage in rat organotypic hippocampal slice cultures. J Biol Chem 2006, 281:20315-20325.
6. Colombo A., Bastone A., Ploia C., Sclip A., Salmona M., Forloni G., Borsello T. JNK regulates APP cleavage and degradation in a model of Alzheimer's disease. Neurobiol Dis 2009, 33:518-525.
7. Cravatt B.F., Demarest K., Patricelli M.P., Bracey M.H., Giang D.K., Martin B.R., Lichtman A.H. Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proc Natl Acad Sci U S A 2001, 98:9371-9376.
8. Daniels W.M., Hendricks J., Salie R., Taljaard J.J. The role of the MAP-kinase superfamily in beta-amyloid toxicity. Metab Brain Dis 2001, 16:175-185.
9. Devane W.A., Hanus L., Breuer A., Pertwee R.G., Stevenson L.A., Griffin G., Gibson D., Mandelbaum A., Etinger A., Mechoulam R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992, 258:1946-1949.
10. + depletion and cell death induced by oxidative stress. J Biol Chem 2003, 278:18426-18433.
11. Ekshyyan O., Aw T.Y. Apoptosis in acute and chronic neurological disorders. Front Biosci 2004, 9:1567-1576.
12. Goutopoulos A., Makriyannis A. From cannabis to cannabinergics: new therapeutic opportunities. Pharmacol Ther 2002, 95:103-117.
13. Grazia Cascio M., Minassi A., Ligresti A., Appendino G., Burstein S., Di Marzo V. A structure-activity relationship study on N-arachidonoyl-amino acids as possible endogenous inhibitors of fatty acid amide hydrolase. Biochem Biophys Res Commun 2004, 314:192-196.
14. Han B.H., Holtzman D.M. BDNF protects the neonatal brain from hypoxic-ischemic injury in vivo via the ERK pathway. J Neurosci 2000, 20:5775-5781.
15. Hayashi T., Tsao L.I., Su T.P. Antiapoptotic and cytotoxic properties of delta opioid peptide [D-Ala(2),D-Leu(5)]enkephalin in PC12 cells. Synapse 2002, 43:86-94.
16. Hsu M.J., Hsu C.Y., Chen B.C., Chen M.C., Ou G., Lin C.H. Apoptosis signal-regulating kinase 1 in amyloid beta peptide-induced cerebral endothelial cell apoptosis. J Neurosci 2007, 27:5719-5729.
17. Kajta M. Apoptosis in the central nervous system: mechanisms and protective strategies. Pol J Pharmacol 2004, 56:689-700.
18. Kelly B.L., Ferreira A. beta-Amyloid-induced dynamin 1 degradation is mediated by N-methyl-D-aspartate receptors in hippocampal neurons. J Biol Chem 2006, 281:28079-28089.
19. Kuperstein F., Yavin E. Pro-apoptotic signaling in neuronal cells following iron and amyloid beta peptide neurotoxicity. J Neurochem 2003, 86:114-125.
20. Ma M.C., Qian H., Ghassemi F., Zhao P., Xia Y. Oxygen-sensitive {delta}-opioid receptor-regulated survival and death signals: novel insights into neuronal preconditioning and protection. J Biol Chem 2005, 280:16208-16218.
21. Mai H., May W.S., Gao F., Jin Z., Deng X. A functional role for nicotine in Bcl2 phosphorylation and suppression of apoptosis. J Biol Chem 2003, 278:1886-1891.
22. Matas D., Juknat A., Pietr M., Klin Y., Vogel Z. Anandamide protects from low serum-induced apoptosis via its degradation to ethanolamine. J Biol Chem 2007, 282:7885-7892.
23. Mechoulam R., Spatz M., Shohami E. Endocannabinoids and neuroprotection. Sci STKE 2002, 2002:re5.
24. Micale V., Mazzola C., Drago F. Endocannabinoids and neurodegenerative diseases. Pharmacol Res 2007, 56:382-392.
25. Miloso M., Scuteri A., Foudah D., Tredici G. MAPKs as mediators of cell fate determination: an approach to neurodegenerative diseases. Curr Med Chem 2008, 15:538-548.
26. Milton N.G. Anandamide and noladin ether prevent neurotoxicity of the human amyloid-beta peptide. Neurosci Lett 2002, 332:127-130.
27. Nie B.M., Jiang X.Y., Cai J.X., Fu S.L., Yang L.M., Lin L., Hang Q., Lu P.L., Lu Y. Panaxydol and panaxynol protect cultured cortical neurons against Abeta25-35-induced toxicity. Neuropharmacology 2008, 54:845-853.
28. Salminen A., Ojala J., Suuronen T., Kaarniranta K., Kauppinen A. Amyloid-beta oligomers set fire to inflammasomes and induce Alzheimer's pathology. J Cell Mol Med 2008, 12:2255-2262.
29. Schomacher M., Muller H.D., Sommer C., Schwab S., Schabitz W.R. Endocannabinoids mediate neuroprotection after transient focal cerebral ischemia. Brain Res 2008, 1240:213-220.
30. Tamagno E., Parola M., Guglielmotto M., Santoro G., Bardini P., Marra L., Tabaton M., Danni O. Multiple signaling events in amyloid beta-induced, oxidative stress-dependent neuronal apoptosis. Free Radic Biol Med 2003, 35:45-58.
31. Tan B., O'Dell D.K., Yu Y.W., Monn M.F., Hughes H.V., Burstein S., Walker J.M. Identification of endogenous acyl amino acids based on a targeted lipidomics approach. J Lipid Res 2010, 51:112-119.
32. Torocsik B., Szeberenyi J. Anisomycin uses multiple mechanisms to stimulate mitogen-activated protein kinases and gene expression and to inhibit neuronal differentiation in PC12 phaeochromocytoma cells. Eur J Neurosci 2000, 12:527-532.
33. Wang Z.J., Li G.M., Nie B.M., Lu Y., Yin M. Neuroprotective effect of the stearic acid against oxidative stress via phosphatidylinositol 3-kinase pathway. Chem Biol Interact 2006, 160:80-87.
34. Xie Z., Tanzi R.E. Alzheimer's disease and post-operative cognitive dysfunction. Exp Gerontol 2006, 41:346-359.
35. Yao L.Y., Lin Q., Niu Y.Y., Deng K.M., Zhang J.H., Lu Y. Synthesis of lipoamino acids and their activity against cerebral ischemic injury. Molecules 2009, 14:4051-4064.
36. Zhang Y.B., Kan M.Y., Yang Z.H., Ding W.L., Yi J., Chen H.Z., Lu Y. Neuroprotective effects of N-stearoyltyrosine on transient global cerebral ischemia in gerbils. Brain Res 2009, 1287:146-156.